Furthermore, recent studies suggest that CAIX inhibition can sensitize cancer cells to oxidative stress and iron-dependent cell death mechanisms, such as ferroptosis and ferroapoptosis, highlighting its potential role in novel combination therapies targeting tumor metabolism and redox balance [7,8]. Here, CA9 is linked to cancer.